https://www.selleckchem.com/products/jke-1674.html
Women with response to primary treatment for advanced ovarian cancer are said to have progression if CA125 increases more than double the upper normal limit (70IU/L) on follow-up. It was, however, noted that large section of women with CA125 35IU/L had disease on imaging. To compare values of CA125 rise at which radiological recurrence can be detected. This is a retrospective observational study where women with advanced epithelial ovarian cancer who underwent interval debulking surgery and completed treatment at Tata Medical Cent
Gefällt mir
Kommentar
Teilen
